Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 801 - 808 of 11617 results
HHS Proposes Plan to Advance Cyber Resiliency in Health Care; OCR Settles Phishing Attack Investigation
December 12, 2023| Blog| Viewpoint
Exploring FDA's Stance on LDTs and AI
December 12, 2023| News
Got an Environmental Issue? Investors Are Scrutinizing Your Response
December 11, 2023| News
Electric Storage Resource Growth and Deployment: A Tale of Two Markets
December 8, 2023| Article| Viewpoint
Workplace Implications of President Biden’s Executive Order Addressing Artificial Intelligence — AI: The Washington Report
December 8, 2023| Article| Viewpoint
Mintz Launches Podcast Series on Women Leaders in Health Care
December 8, 2023| Blog| Viewpoint
FCC Partners With States to Increase on Privacy and Data Protection Investigations, Signaling Increased Focus on Future Enforcement
December 8, 2023| Blog| Viewpoint
A Timeline of Biden’s AI Executive Order — AI: The Washington Report
December 7, 2023| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.
Events
Podcasts
The ‘Third Inning’ of the Energy Transition
December 6, 2024| Podcast|
Mintz on Air - Predictions and Practical Policies
November 25, 2024| Podcast|